A citation-based method for searching scientific literature


List of co-cited articles
276 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial.
Jill Hamilton, Elizabeth Cummings, Vera Zdravkovic, Diane Finegood, Denis Daneman. Diabetes Care 2003
99
45

The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients.
Laurent Meyer, Philip Bohme, Irene Delbachian, Philippe Lehert, Nathalie Cugnardey, Pierre Drouin, Bruno Guerci. Diabetes Care 2002
54
43


Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.
Søren Søgaard Lund, Lise Tarnow, Anne Sofie Astrup, Peter Hovind, Peter Karl Jacobsen, Amra Ciric Alibegovic, Ida Parving, Lotte Pietraszek, Merete Frandsen, Peter Rossing,[...]. PLoS One 2008
53
32

Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients.
H Gin, C Messerchmitt, E Brottier, J Aubertin. Metabolism 1985
62
27

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.
S S Lund, L Tarnow, A S Astrup, P Hovind, P K Jacobsen, A C Alibegovic, I Parving, L Pietraszek, M Frandsen, P Rossing,[...]. Diabetes Obes Metab 2009
29
34


The use of metformin in type 1 diabetes: a systematic review of efficacy.
S Vella, L Buetow, P Royle, S Livingstone, H M Colhoun, J R Petrie. Diabetologia 2010
111
24

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes.
G Pagano, V Tagliaferro, Q Carta, M T Caselle, C Bozzo, F Vitelli, M Trovati, E Cocuzza. Diabetologia 1983
70
21

Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus.
Tatsuhiko Urakami, Shigeo Morimoto, Misao Owada, Kensuke Harada. Pediatr Int 2005
16
50

The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control.
Iben Brock Jacobsen, Jan Erik Henriksen, Henning Beck-Nielsen. Basic Clin Pharmacol Toxicol 2009
33
24

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
18

Metformin adjunctive therapy with insulin improves glycemic control in patients with type 1 diabetes mellitus: a pilot study.
Ricardo Gómez, Moinuddin H Mokhashi, Jayashree Rao, Alfonso Vargas, Terry Compton, Robert McCarter, Stuart A Chalew. J Pediatr Endocrinol Metab 2002
17
41


Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents.
Shereen Abdelghaffar, Abdelhamid M Attia. Cochrane Database Syst Rev 2009
35
20

Dimethyldiguanide in the treatment of diabetic children.
A W FERGUSON, P L DE LA HARPE, J W FARQUHAR. Lancet 1961
20
25

[Metformin in the treatment of type 1 diabetics--a placebo controlled study].
S Lacigová, Z Rusavý, Z Jankovec, P Kyselová. Cas Lek Cesk 2001
8
62


Metformin.
C J Bailey, R C Turner. N Engl J Med 1996
13


Addressing insulin resistance in Type 1 diabetes.
T T L Pang, P Narendran. Diabet Med 2008
43
13

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study.
Trevor J Orchard, Jon C Olson, John R Erbey, Katherine Williams, Kimberly Y-Z Forrest, Leslie Smithline Kinder, Demetrius Ellis, Dorothy J Becker. Diabetes Care 2003
289
13

Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study.
Kristen J Nadeau, Kelsey Chow, Suhyla Alam, Kara Lindquist, Sarah Campbell, Kim McFann, Georgeanna Klingensmith, Phillipe Walravens. Pediatr Diabetes 2015
46
13

Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?
S J Cleland, B M Fisher, H M Colhoun, N Sattar, J R Petrie. Diabetologia 2013
89
13

Can clinical factors estimate insulin resistance in type 1 diabetes?
K V Williams, J R Erbey, D Becker, S Arslanian, T J Orchard. Diabetes 2000
246
10



Study of the effect of metformin on platelet aggregation in insulin-dependent diabetics.
H Gin, G Freyburger, M Boisseau, J Aubertin. Diabetes Res Clin Pract 1989
36
11

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
10

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
Adriaan Kooy, Jolien de Jager, Philippe Lehert, Daniël Bets, Michiel G Wulffelé, Ab J M Donker, Coen D A Stehouwer. Arch Intern Med 2009
228
10

Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.
Irene E Schauer, Janet K Snell-Bergeon, Bryan C Bergman, David M Maahs, Adam Kretowski, Robert H Eckel, Marian Rewers. Diabetes 2011
134
10

Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.
Kristen J Nadeau, Judith G Regensteiner, Timothy A Bauer, Mark S Brown, Jennifer L Dorosz, Amber Hull, Phil Zeitler, Boris Draznin, Jane E B Reusch. J Clin Endocrinol Metab 2010
172
10

Estimated insulin sensitivity and cardiovascular disease risk factors in adolescents with and without type 1 diabetes.
Brian J Specht, R Paul Wadwa, Janet K Snell-Bergeon, Kristen J Nadeau, Franziska K Bishop, David M Maahs. J Pediatr 2013
53
10

Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study.
Paweł Burchardt, Agnieszka Zawada, Piotr Tabaczewski, Dariusz Naskręt, Jolanta Kaczmarek, Justyna Marcinkaniec, Bogna Wierusz-Wysocka, Henryk Wysocki. Pol Arch Med Wewn 2013
13
30


Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study.
G Riccardi, R Giacco, M Parillo, S Turco, A A Rivellese, M R Ventura, S Contadini, G Marra, M Monteduro, F Santeusanio,[...]. Diabet Med 1999
21
14


The effect of rosiglitazone on overweight subjects with type 1 diabetes.
Suzanne M Strowig, Philip Raskin. Diabetes Care 2005
38
8

Pioglitazone as adjunctive therapy in adolescents with type 1 diabetes.
Vera Zdravkovic, Jill K Hamilton, Denis Daneman, Elizabeth A Cummings. J Pediatr 2006
30
10

Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas.
H Gin, G Slama, P Weissbrodt, T Poynard, P Vexiau, J C Klein, G Tchobroutsky. Diabetologia 1982
28
10

Metformin: new understandings, new uses.
Ripudaman S Hundal, Silvio E Inzucchi. Drugs 2003
183
8

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
P M Kearney, L Blackwell, R Collins, A Keech, J Simes, R Peto, J Armitage, C Baigent. Lancet 2008
8

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.
S P Laing, A J Swerdlow, S D Slater, A C Burden, A Morris, N R Waugh, W Gatling, P J Bingley, C C Patterson. Diabetologia 2003
440
8



Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.
Kazunari Matsumoto, Yasunori Sera, Yasuyo Abe, Tan Tominaga, Yukitaka Yeki, Seibei Miyake. Diabetes Res Clin Pract 2004
51
8

Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes.
Shalamar D Sibley, Jerry P Palmer, Irl B Hirsch, John D Brunzell. J Clin Endocrinol Metab 2003
40
8


Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).
Lena M Thorn, Carol Forsblom, Johan Fagerudd, Merlin C Thomas, Kim Pettersson-Fernholm, Markku Saraheimo, Johan Wadén, Mats Rönnback, Milla Rosengård-Bärlund, Clas-Göran Af Björkesten,[...]. Diabetes Care 2005
250
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.